Ignyta Inc. (RXDX:NASDAQ) Ignyta Inc. (RXDX:NASDAQ) has a $420M market cap. Ignyta takes a targeted approach to oncology, focusing on integrated therapies and diagnostics. This methodology derisks its clinical trials. The company has an efficient […]

Hemispherx Biopharma, Inc. (NYSEMKT:HEB) Hemispherx Biopharma, Inc. (NYSEMKT:HEB) has been around for more than a couple of years and has had a rough and up to this point for the most part non-productive history. There […]

Fate Therapeutics Inc. (FATE:NASDAQ) Fate Therapeutics Inc. (FATE:NASDAQ) has a $115M market capitalization and the organization is called as a shrouded diamond in the cell treatment space. Fate Therapeutics is growing little particles to balance/improve […]

Evoke Pharma (NASDAQ:EVOK) Evoke Pharma (NASDAQ:EVOK) is a rising California-based pharmaceutical organization that is creating EVK-001, a nasal splash detailing of metoclopramide, a prokinetic specialist (builds gut motility) for use in gastroparesis in ladies. The […]

FibroGen, Inc. (FGEN) FibroGen, Inc. (FGEN) is a Biopharmaceutical organization. Lead pipeline includes roxadustat, which is a hypoxia-inducible component prolyl hydroxylase (HIF-PH) inhibitor that fortifies erythropoiesis, directs iron digestion system, and decreases hepcidin. Basically, it […]

Shares of Eleven Biotherapeutics (EBIO) Shares of Eleven Biotherapeutics (EBIO) were higher on substantial exchanging volume in recent weeks as the Cambridge, MA-based biopharmaceutical organization consented to buy the private held organization Viventia Bio in […]

Enteromedics (NASDAQ:ETRM) Enteromedics (NASDAQ:ETRM) speculators began off the week with a dreadful notification from the organization. A 8-K was recorded on Monday morning, expressing that the organization was in receipt of a de-posting notice from […]

Shares of business biomaterial organization Amedica Corp (AMDA) Shares of business biomaterial organization Amedica Corp (AMDA) are taking off more than 33% after they declared a dispersion manage Shandong Weigao Orthopedic Device Company Limited. Under […]

NASDAQ: AKBA Akebia Therapeutics Inc Stock Akebia’s key item being developed is Vadadustat, orally regulated inhibitor of hypoxia-initiating component prolyl hydroxylase (HIF-PH) protein which is being tried in two Phase 3 trials in non-DD, CKD […]

Yamana Gold (NYSE:AUY) Yamana Gold (NYSE:AUY) has done truly well this year, rising just about 150% driven by the rally in gold prices. Notwithstanding, over the previous month, Yamana’s shares have gotten hammered, losing near […]